PLoS genetics

Activation of the ATF-7 protein by PMK-1 controls immune defense in C. elegans

Updated

Abstract

C. elegans , a transcription factor, plays a pivotal role in regulating innate immunity via the p38 MAPK pathway.

  • ATF-7 functions as a repressor of PMK-1-regulated immune genes that switches to an activator upon phosphorylation by PMK-1.
  • Loss-of-function mutations in atf-7 restore baseline expression of PMK-1-regulated genes but hinder gene induction in response to the pathogen Pseudomonas aeruginosa PA14.
  • The mechanism of ATF-7's switch from repressor to activator is similar to the regulatory functions of ancestral proteins in yeast during osmotic stress response.
  • The regulation of the ATF2/ATF7/CREB5 family by p38 MAPK may represent an ancient mechanism for innate immunity control in metazoans.

Simplified

Key figures

Figure 9
regulation of immune gene expression in C. elegans with and without activation
Highlights how changes ATF-7’s role from immune repression to activation in response to pathogens
pgen.1000892.g009
  • Panel A
    ATF-7 represses expression when PMK-1 is inactive
  • Panel B
    Phosphorylated PMK-1 activates ATF-7, switching it to promote immune gene expression upon pathogen exposure
Figure 1
Wild-type vs mutants: immune signaling, protein activation, and survival on pathogen
Highlights reduced survival and altered activation in atf-7 mutants, spotlighting immune signaling differences
pgen.1000892.g001
  • Panel A
    Fluorescence microscopy images showing expression in wild-type and two atf-7 mutant strains in one-day-old adults
  • Panel B
    Survival curves of L4 larvae wild-type and atf-7(qd22) and atf-7(qd22 qd130) mutants on PA14; mutants show reduced survival compared to wild-type
  • Panel C
    Immunoblot detecting total PMK-1 and activated (phosphorylated) PMK-1 in wild-type, tir-1(qd4), and atf-7(qd22) worm lysates
  • Panel D
    Survival curves of L4 larvae wild-type, multiple atf-7 mutants, and on PA14; mutants show reduced survival compared to wild-type, with no difference between trans-heterozygotes and mutants
Figure 2
Mutations, sequence similarity, and evolutionary relationships of C. elegans
Anchors ATF-7’s evolutionary conservation and mutation mapping to understand its role in innate immunity regulation
pgen.1000892.g002
  • Panel A
    Diagram of atf-7 gene showing mutation sites with amino acid changes and domain location
  • Panel B
    of DNA binding domains comparing C. elegans ATF-7 with human ATF-2 and related proteins
  • Panel C
    Phylogenetic tree grouping C. elegans ATF-7 with mammalian ATF2/ATF7/CREB5 family of bZIP transcription factors
Figure 3
Wild-type vs mutant worms: expression and survival during Pseudomonas aeruginosa infection
Highlights increased GFP expression and improved survival in double mutants compared to single or mutants.
pgen.1000892.g003
  • Panel A
    Fluorescence microscopy images of GFP expression in one-day-old adults for pmk-1() mutants and (qd22 qd130); pmk-1(km25) double mutants, showing visibly brighter GFP signal in the double mutants.
  • Panel B
    Survival curves of L4 larval stage wild-type, atf-7(qd22 qd130), atf-7(qd22 qd130); pmk-1(km25), and pmk-1(km25) mutants on , with double mutants showing significantly higher survival than pmk-1(km25) mutants.
  • Panel C
    Fluorescence microscopy images of GFP expression in one-day-old adults for sek-1(km4) mutants and atf-7(qd22 qd130); sek-1(km4) double mutants, with the double mutants appearing to have brighter GFP signal.
  • Panel D
    Survival curves of L4 larval stage wild-type, atf-7(qd22 qd130), atf-7(qd22 qd130); sek-1(km4), and sek-1(km4) mutants on Pseudomonas aeruginosa PA14, showing significantly higher survival in double mutants compared to sek-1(km4) mutants.
Figure 4
Expression levels of -regulated genes in C. elegans under normal and pathogen-exposed conditions
Highlights how gene expression changes with pathogen exposure and shows reduced immune gene activation in pmk-1 mutants
pgen.1000892.g004
  • Panel A
    measurement of relative expression of genes T24B8.5, C17H12.8, and K08D8.5 in L4 larvae of wild-type, (qd22), and pmk-1() genotypes on bacteria; atf-7(qd22) and pmk-1(km25) show reduced expression compared to wild-type
  • Panel B
    qRT-PCR measurement of relative expression of the same genes after 4 hours exposure to pathogen or OP50 control in multiple genotypes; wild-type shows increased expression on PA14, while pmk-1(km25) shows reduced expression; atf-7 mutants show varied expression with some reduced relative to wild-type on OP50
1 / 5

Full Text

What this is

  • This research investigates the role of , a transcription factor in Caenorhabditis elegans, in regulating innate immunity through the p38 MAPK pathway.
  • The study identifies as a key regulator that switches from a repressor to an activator of immune response genes upon phosphorylation by .
  • Findings suggest that this regulatory mechanism is conserved across species, including mammals, indicating its fundamental role in innate immunity.

Essence

  • regulates innate immunity in C. elegans by switching from a repressor to an activator of -regulated genes upon phosphorylation by p38 MAPK.

Key takeaways

  • serves as a transcriptional regulator of the -mediated immune response, switching roles based on its phosphorylation state.
  • Loss-of-function mutations in restore basal expression of -regulated genes but prevent their induction by pathogens, highlighting 's dual role.
  • The findings suggest that the regulation of by represents an ancient mechanism for controlling innate immunity across metazoans.

Caveats

  • The study primarily focuses on C. elegans, and while it suggests conservation in mammals, direct evidence in mammalian systems remains to be established.
  • The genetic interactions and phenotypes observed may not fully capture the complexity of innate immune responses in more complex organisms.

Definitions

  • ATF-7: A transcription factor in C. elegans that regulates immune responses through the PMK-1 p38 MAPK pathway.
  • PMK-1: A p38 mitogen-activated protein kinase involved in innate immunity signaling in C. elegans.

Simplified

Funding

Competing interests

The authors have declared that no competing interests exist.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free